| CRK |
CRK: Proto-oncogene C-crk |
PIP5K2A |
PIP4K2A, PIP5K2, PIP5K2A: Phosphatidylinositol-5-phosphate 4-kinase type-2 alpha |
0.36 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
EPHA10 |
EPHA10: Ephrin type-A receptor 10 precursor |
0.36 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
MRGPRX4 |
IPI00438588 |
0.36 |
Evidence |
|
| ZBTB25 |
ZBTB25, KUP, ZNF46: Zinc finger and BTB domain-containing protein 25 |
SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
0.36 |
Evidence |
|
| HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
HLA-DQA1 |
IPI00736570 |
0.36 |
Evidence |
|
| ECM2 |
ECM2: Extracellular matrix protein 2 precursor |
ROBO2 |
IPI00385980 |
0.36 |
Evidence |
|
| PPFIA3 |
PPFIA3, KIAA0654: Liprin-alpha-3 |
DBNL |
DBNL, CMAP, PP5423, SH3P7: Drebrin-like protein |
0.36 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
IGHA1 |
IPI00719411 |
0.36 |
Evidence |
|
| GDF9 |
GDF9: Growth/differentiation factor 9 precursor |
GDF6 |
GDF6, GDF16: Growth/differentiation factor 6 precursor |
0.36 |
Evidence |
|
| RGS10 |
IPI00013454 |
GPR35 |
CDNA FLJ16773 fis, clone BRAWH3046240, highly similar to Probable G protein-coup |
0.36 |
Evidence |
|
| ADAM12 |
ADAM12, MLTN: ADAM 12 precursor |
MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
0.36 |
Evidence |
|
| FFAR1 |
FFAR1, GPR40: Free fatty acid receptor 1 |
RGS7 |
RGS7: Regulator of G-protein signaling 7 |
0.36 |
Evidence |
|
| STX16 |
STX16: Syntaxin-16 |
STX6 |
STX6: Syntaxin-6 |
0.36 |
Evidence |
O
|
| HRK |
HRK, BID3: Activator of apoptosis harakiri |
RTN4 |
RTN4, KIAA0886, My043, NOGO, SP1507: Reticulon-4 |
0.36 |
Evidence |
|
| HIST2H2AC |
HIST2H2AC, H2AFQ: Histone H2A type 2-C |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
0.36 |
Evidence |
|
| RAB5A |
RAB5A, RAB5: Ras-related protein Rab-5A |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
0.36 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.36 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.36 |
Evidence |
|
| DNALI1 |
DNALI1: Axonemal dynein light intermediate polypeptide 1 |
SON |
|
0.36 |
Evidence |
|
| EYA3 |
EYA3, RP11-460I13.4-001, hCG_1640928: Eyes absent homolog 3 |
MLLT4 |
IPI00023461 |
0.36 |
Evidence |
|
| R3HDM2 |
R3HDM2, KIAA1002: R3H domain-containing protein 2 |
EYA3 |
EYA3, RP11-460I13.4-001, hCG_1640928: Eyes absent homolog 3 |
0.36 |
Evidence |
|
| GORASP2 |
IPI00031241 |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
0.36 |
Evidence |
|
| SMARCC1 |
IPI00556118 |
EYA3 |
EYA3, RP11-460I13.4-001, hCG_1640928: Eyes absent homolog 3 |
0.36 |
Evidence |
|
| ATF2 |
ATF2, CREB2, CREBP1: Cyclic AMP-dependent transcription factor ATF-2 |
NFIL3 |
NFIL3, E4BP4, IL3BP1: Nuclear factor interleukin-3-regulated protein |
0.36 |
Evidence |
|
| ATF2 |
ATF2, CREB2, CREBP1: Cyclic AMP-dependent transcription factor ATF-2 |
GTPBP2 |
GTPBP2: GTP-binding protein 2 |
0.36 |
Evidence |
|